Brian Mc Kelligon is President and CEO of Akoya Biosciences, Inc.. Currently has a direct ownership of 224,733 shares of AKYA, which is worth approximately $624,757. The most recent transaction as insider was on Sep 07, 2022, when has been sold 5,000 shares (Common Stock) at a price of $0.3 per share, resulting in proceeds of $1,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 225K
0% 3M change
47.31% 12M change
Total Value Held $624,757

Brian McKelligon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 07 2022
BUY
Exercise of conversion of derivative security
$1,500 $0.3 p/Share
5,000 Added 5.56%
85,000 Common Stock
Jun 15 2022
SELL
Open market or private sale
$51,250 $10.25 p/Share
5,000 Reduced 5.88%
80,000 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
$1,500 $0.3 p/Share
5,000 Added 5.56%
85,000 Common Stock
Mar 23 2022
BUY
Grant, award, or other acquisition
-
80,000 Added 50.0%
80,000 Common Stock
BM

Brian Mc Kelligon

President and CEO
Marlborough, MA

Track Institutional and Insider Activities on AKYA

Follow Akoya Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKYA shares.

Notify only if

Insider Trading

Get notified when an Akoya Biosciences, Inc. insider buys or sells AKYA shares.

Notify only if

News

Receive news related to Akoya Biosciences, Inc.

Track Activities on AKYA